IONS - Comprehensive Filing Intelligence

FY 2025•10-K•Filed Feb 26, 2026
5.0/10
Filing Health:CAUTION

Notable concerns that warrant closer review

Executive Summary

Liquidity is considered sufficient for planned operations, supported by existing resources and various financing options.. Working capital decreased due to a reclassification of debt related to upcoming maturities.. No significant off-balance sheet exposures or commitments were disclosed beyond standard operating leases and routine legal proceedings.. Revenue increased 33.8% year-over-year.

Top Concerns

  • !The company has a negative operating margin (-0.4%) and a cash conversion ratio below 1.0 (0.70x), indicating potential issues with earnings quality and cash flow generation.
  • !The company has a high debt-to-equity ratio of 3.60x, which could pose financial risks.
  • !No significant off-balance sheet exposures or commitments were disclosed beyond standard operating leases and routine legal proceedings.
  • !Regulatory and Pricing Pressures (IRA) (high)
  • !Intense Competition (high)

Top Positives

  • +Revenue growth driven by strong performance in royalties and collaborative agreements, with new product sales contributing.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

6.0/10

Management tone is confidently optimistic.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

5.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

3.0/10

Overall risk profile shows regulatory and pricing pressures (ira) as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

7.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.